ETSU Pharmacology Exam 4 with correct
| | | | | |
answers
The |patient |with |a |deep |vein |thrombosis |in |her |lower |leg |and |was |started |on |warfarin. |She |
asks |the |nurse |how |warfarin |works. |What |is |the |nurse's |best |response?
a. |"warfarin |will |help |dissolve |the |blood |clots"
b. |"warfarin |is |given |with |thrombolytics |to |help |break |up |clots"
c. |"warfarin |prevents |new |clots |from |forming" |
d. |"warfarin |dilates |the |veins |to |improve |blood |flow" |- |correct |answer |C.
The |nurse |has |several |patients |receiving |warfarin. |Which |INR |(s) |should |concern |the |nurse? |
Select |all |that |apply
a. |1.2
b. |1.4
c. |1.8
d. |2.0
e. |2.4 |- |correct |answer |A., |B., |C.
What |is |one |of |the |primary |reasons |LMWHs |are |given?
a. |enhance |the |action |of |warfarin
b. |prevent |cerebrovascular |accidents
c. |prevention |of |DVTs |after |hip |or |knee |surgery |
d. |treatment |of |acute |myocardial |infarction |- |correct |answer |C.
Which |drug |is |not |considered |a |LMWH? |Select |all |that |apply
a. |enoxaparin |sodium
b. |clopidogrel
,c. |dalteparin
d. |apixaban |- |correct |answer |B., |D.
The |patient, |58 |years |old, |has |unstable |angina |and |is |having |an |emergent |coronary |angioplasty
|(PCTA). |The |nurse |is |completing |preprocedure |teaching |and |explains |that |he |will |be |receiving |
a |medication |right |before |the |procedure |and |then |for |the |next |12 |hours |by |IV |drip |to |prevent |
ischemia. |What |drug |is |the |nurse |teaching |the |patient |about? |
a. |abciximab
b. |aminocaproic |acid
c. |protamine |sulfate |
d. |warfarin |- |correct |answer |A.
The |patient |weighs |168 |pounds |and |is |going |to |receive |abciximab |for |unstable |angina. |What |is
|the |correct |dosage |for |a |continuous |infusion?
a. |9.5 |mcg/min
b. |19 |mcg/min
c. |25 |mcg/min
d. |42 |mcg/min |- |correct |answer |A.
Which |statement |best |describes |clopidogrel?
a. |it |is |the |most |effective |anticoagulant |when |used |with |ibuprofen |
b. |it |is |most |effective |when |prescribed |as |a |single |drug |to |prevent |stroke
c. |it |is |an |inexpensive |alternative |to |warfarin
d. |it |can |be |used |together |with |aspirin |after |myocardial |infarction |or |cerebrovascular |accident |
to |prevent |platelet |aggregation |- |correct |answer |D.
The |72-year-old |patient |has |a |history |of |atrial |fibrillation |and |has |been |discharged |from |the |
hospital |on |warfarin. |He |was |taking |heparin |before |being |changed |to |warfarin |for |discharge. |
With |regards |to |lab |monitoring, |what |is |a |priority |teaching |intervention |for |the |nurse?
a. |"INR |will |be |monitored |closely"
, b. |"Periodic |evaluation |of |your |electrolytes |is |very |important"
c. |"your |blood |must |be |monitored |for |BUN/ |creatinine |values |to |evaluate |for |new |renal |
failure"
d. |"you |will |not |need |any |further |lab |work |while |taking |this |medication" |- |correct |answer |A.
Enoxaparin |sodium |is |an |anticoagulant |used |to |prevent |and |treat |deep |vein |thrombosis |and |
pulmonary |embolism. |To |which |category |does |this |drug |belong?
a. |oral |anticoagulant
b. |low-molecular- |weight |heparin
c. |standard |heparin
d. |thrombolytic |- |correct |answer |B.
The |3-year-old |patient |has |gotten |into |a |box |of |rat |poison |under |the |sink. |The |family |brings |
the |box |to |the |emergency |department, |and |the |main |ingredient |is |heparin. |What |priority |
medication |will |the |nurse |prepare |to |administer?
a. |anagrelide
b. |protamine |sulfate |
c. |ticlopidine
d. |vitamin |K |(phytonadione) |- |correct |answer |D.
What |is |the |protein-binding |power |of |warfarin?
a. |highly |protein-bound
b. |low |protein-bound
c. |not |protein-bound |at |all
d. |moderately |protein-bound |- |correct |answer |A.
The |patient |is |given |heparin |for |early |treatment |of |deep |vein |thrombosis. |Later, |warfarin |is |
prescribed. |If |the |patient |is |also |taking |fluoxetine, |which |is |highly |protein-bound, |what |might |
occur?
a. |drug |displacement |of |the |highly |protein-bound |drug |but |not |displacement |of |warfarin
| | | | | |
answers
The |patient |with |a |deep |vein |thrombosis |in |her |lower |leg |and |was |started |on |warfarin. |She |
asks |the |nurse |how |warfarin |works. |What |is |the |nurse's |best |response?
a. |"warfarin |will |help |dissolve |the |blood |clots"
b. |"warfarin |is |given |with |thrombolytics |to |help |break |up |clots"
c. |"warfarin |prevents |new |clots |from |forming" |
d. |"warfarin |dilates |the |veins |to |improve |blood |flow" |- |correct |answer |C.
The |nurse |has |several |patients |receiving |warfarin. |Which |INR |(s) |should |concern |the |nurse? |
Select |all |that |apply
a. |1.2
b. |1.4
c. |1.8
d. |2.0
e. |2.4 |- |correct |answer |A., |B., |C.
What |is |one |of |the |primary |reasons |LMWHs |are |given?
a. |enhance |the |action |of |warfarin
b. |prevent |cerebrovascular |accidents
c. |prevention |of |DVTs |after |hip |or |knee |surgery |
d. |treatment |of |acute |myocardial |infarction |- |correct |answer |C.
Which |drug |is |not |considered |a |LMWH? |Select |all |that |apply
a. |enoxaparin |sodium
b. |clopidogrel
,c. |dalteparin
d. |apixaban |- |correct |answer |B., |D.
The |patient, |58 |years |old, |has |unstable |angina |and |is |having |an |emergent |coronary |angioplasty
|(PCTA). |The |nurse |is |completing |preprocedure |teaching |and |explains |that |he |will |be |receiving |
a |medication |right |before |the |procedure |and |then |for |the |next |12 |hours |by |IV |drip |to |prevent |
ischemia. |What |drug |is |the |nurse |teaching |the |patient |about? |
a. |abciximab
b. |aminocaproic |acid
c. |protamine |sulfate |
d. |warfarin |- |correct |answer |A.
The |patient |weighs |168 |pounds |and |is |going |to |receive |abciximab |for |unstable |angina. |What |is
|the |correct |dosage |for |a |continuous |infusion?
a. |9.5 |mcg/min
b. |19 |mcg/min
c. |25 |mcg/min
d. |42 |mcg/min |- |correct |answer |A.
Which |statement |best |describes |clopidogrel?
a. |it |is |the |most |effective |anticoagulant |when |used |with |ibuprofen |
b. |it |is |most |effective |when |prescribed |as |a |single |drug |to |prevent |stroke
c. |it |is |an |inexpensive |alternative |to |warfarin
d. |it |can |be |used |together |with |aspirin |after |myocardial |infarction |or |cerebrovascular |accident |
to |prevent |platelet |aggregation |- |correct |answer |D.
The |72-year-old |patient |has |a |history |of |atrial |fibrillation |and |has |been |discharged |from |the |
hospital |on |warfarin. |He |was |taking |heparin |before |being |changed |to |warfarin |for |discharge. |
With |regards |to |lab |monitoring, |what |is |a |priority |teaching |intervention |for |the |nurse?
a. |"INR |will |be |monitored |closely"
, b. |"Periodic |evaluation |of |your |electrolytes |is |very |important"
c. |"your |blood |must |be |monitored |for |BUN/ |creatinine |values |to |evaluate |for |new |renal |
failure"
d. |"you |will |not |need |any |further |lab |work |while |taking |this |medication" |- |correct |answer |A.
Enoxaparin |sodium |is |an |anticoagulant |used |to |prevent |and |treat |deep |vein |thrombosis |and |
pulmonary |embolism. |To |which |category |does |this |drug |belong?
a. |oral |anticoagulant
b. |low-molecular- |weight |heparin
c. |standard |heparin
d. |thrombolytic |- |correct |answer |B.
The |3-year-old |patient |has |gotten |into |a |box |of |rat |poison |under |the |sink. |The |family |brings |
the |box |to |the |emergency |department, |and |the |main |ingredient |is |heparin. |What |priority |
medication |will |the |nurse |prepare |to |administer?
a. |anagrelide
b. |protamine |sulfate |
c. |ticlopidine
d. |vitamin |K |(phytonadione) |- |correct |answer |D.
What |is |the |protein-binding |power |of |warfarin?
a. |highly |protein-bound
b. |low |protein-bound
c. |not |protein-bound |at |all
d. |moderately |protein-bound |- |correct |answer |A.
The |patient |is |given |heparin |for |early |treatment |of |deep |vein |thrombosis. |Later, |warfarin |is |
prescribed. |If |the |patient |is |also |taking |fluoxetine, |which |is |highly |protein-bound, |what |might |
occur?
a. |drug |displacement |of |the |highly |protein-bound |drug |but |not |displacement |of |warfarin
